BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 29256329)

  • 1. Utilization and Survival of Postoperative Radiation or Chemoradiation for pT1-2N1M0 Head and Neck Cancer.
    Lee A; Givi B; Roden DF; Tam MM; Wu SP; Gerber NK; Hu KS; Schreiber D
    Otolaryngol Head Neck Surg; 2018 Apr; 158(4):677-684. PubMed ID: 29256329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond Positive Margins and Extracapsular Extension: Evaluating the Utilization and Clinical Impact of Postoperative Chemoradiotherapy in Resected Locally Advanced Head and Neck Cancer.
    Trifiletti DM; Smith A; Mitra N; Grover S; Lukens JN; Cohen RB; Read P; Mendenhall WM; Lin A; Swisher-McClure S
    J Clin Oncol; 2017 May; 35(14):1550-1560. PubMed ID: 28475848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis.
    Woody NM; Ward MC; Koyfman SA; Reddy CA; Geiger J; Joshi N; Burkey B; Scharpf J; Lamarre E; Prendes B; Adelstein DJ
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):784-792. PubMed ID: 28602410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of concomitant chemoradiation on survival for patients with T1-2N1 head and neck cancer.
    Zumsteg ZS; Kim S; David JM; Yoshida EJ; Tighiouart M; Shiao SL; Scher K; Mita A; Sherman EJ; Lee NY; Ho AS
    Cancer; 2017 May; 123(9):1555-1565. PubMed ID: 28001302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of care and outcomes of adjuvant therapy for high-risk head and neck cancer after surgery.
    Osborn VW; Givi B; Rineer J; Roden D; Sheth N; Lederman A; Katsoulakis E; Hu K; Schreiber D
    Head Neck; 2018 Jun; 40(6):1254-1262. PubMed ID: 29451961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative lymph node burden as a 'very-high-risk' factor identifying head and neck cancer patients benefiting from postoperative chemoradiation.
    Zumsteg ZS; Luu M; Kim S; Tighiouart M; Mita A; Scher KS; Lu DJ; Shiao SL; Mallen-St Clair J; Ho AS
    Ann Oncol; 2019 Jan; 30(1):76-84. PubMed ID: 30395159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of adjuvant therapy in resected head and neck cancer with high-risk features.
    Ajmani GS; Nocon CC; Wang CH; Bhayani MK
    Oral Oncol; 2017 Nov; 74():15-20. PubMed ID: 29103745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemoradiation does not improve survival in elderly patients with high-risk resected head and neck cancer.
    Giacalone NJ; Qureshi MM; Mak KS; Kirke D; Patel SA; Shah BA; Salama AR; Jalisi S; Truong MT
    Laryngoscope; 2018 Apr; 128(4):831-840. PubMed ID: 28833217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.
    Iyer NG; Tan DS; Tan VK; Wang W; Hwang J; Tan NC; Sivanandan R; Tan HK; Lim WT; Ang MK; Wee J; Soo KC; Tan EH
    Cancer; 2015 May; 121(10):1599-607. PubMed ID: 25639864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase III randomized trial of preoperative concurrent chemoradiotherapy versus preoperative radiotherapy for patients with locally advanced head and neck squamous cell carcinoma.
    Yi J; Huang X; Xu Z; Liu S; Wang X; He X; Luo D; Luo J; Xiao J; Zhang S; Wang K; Qu Y; Tang Y; Liu W; Xu G; Gao L; Wang D
    Oncotarget; 2017 Jul; 8(27):44842-44850. PubMed ID: 28179586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of adjuvant chemoradiotherapy in T4N0 stage IV head and neck cancer: A National Cancer Database analysis.
    Kirke DN; Qureshi MM; Kamran SC; Ezzat W; Jalisi S; Salama A; Everett PC; Truong MT
    Head Neck; 2018 Jun; 40(6):1174-1184. PubMed ID: 29417687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary surgery with or without postoperative radiotherapy in early stage squamous cell carcinoma in the anal canal and anal margin.
    Leon O; Hagberg O; Johnsson A
    Acta Oncol; 2018 Sep; 57(9):1209-1215. PubMed ID: 29490558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microscopic Extranodal Extension in HPV-Negative Head and Neck Cancer and the Role of Adjuvant Chemoradiation.
    Yan F; Li H; de Almeida JR; Kaczmar JM; Pipkorn P; Zenga J; Richardson MS; Neskey DM; Sharma AK; Day TA; Graboyes EM
    Otolaryngol Head Neck Surg; 2021 Oct; 165(4):536-549. PubMed ID: 33618570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of up-front transoral robotic surgery in tailoring adjuvant therapy.
    Gildener-Leapman N; Kim J; Abberbock S; Choby GW; Mandal R; Duvvuri U; Ferris RL; Kim S
    Head Neck; 2016 Aug; 38(8):1201-7. PubMed ID: 27225507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
    Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer.
    David JM; Ho AS; Luu M; Yoshida EJ; Kim S; Mita AC; Scher KS; Shiao SL; Tighiouart M; Zumsteg ZS
    Cancer; 2017 Oct; 123(20):3933-3942. PubMed ID: 28640546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival outcomes of patients with advanced oral cavity squamous cell carcinoma treated with multimodal therapy: a multi-institutional analysis.
    Zhang H; Dziegielewski PT; Biron VL; Szudek J; Al-Qahatani KH; O'Connell DA; Harris JR; Seikaly H
    J Otolaryngol Head Neck Surg; 2013 Apr; 42(1):30. PubMed ID: 23672952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative chemoradiotherapy in patients with head and neck cancer aged 70 or older with positive margins or extranodal extension and the influence of nodal classification.
    Yoshida EJ; Luu M; David JM; Kim S; Mita A; Scher K; Shiao SL; Tighiouart M; Ho AS; Zumsteg ZS
    Head Neck; 2018 Jun; 40(6):1228-1236. PubMed ID: 29417700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating Adjuvant Therapy With Chemoradiation vs Radiation Alone for Patients With HPV-Negative N2a Head and Neck Cancer.
    Yan F; Li H; Kaczmar JM; Sharma AK; Day TA; Neskey DM; Pipkorn P; Zenga J; Graboyes EM
    JAMA Otolaryngol Head Neck Surg; 2020 Dec; 146(12):1109-1119. PubMed ID: 32790830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative concurrent chemotherapy and radiotherapy for high-risk cutaneous squamous cell carcinoma of the head and neck.
    Tanvetyanon T; Padhya T; McCaffrey J; Kish JA; Deconti RC; Trotti A; Rao NG
    Head Neck; 2015 Jun; 37(6):840-5. PubMed ID: 24623654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.